Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07DTI
|
||||
Former ID |
DIB019528
|
||||
Drug Name |
compound 5
|
||||
Drug Type |
Small molecular drug
|
||||
Formula |
C14H13NO5
|
||||
InChI |
InChI=1S/C23H33ClN2O3/c1-3-26(17-18-27)16-6-4-5-7-19-8-12-21(13-9-19)25(2)23(28)29-22-14-10-20(24)11-15-22/h10-11,14-15,19,21,27H,3-4,6,8-9,12-13,16-18H2,1-2H3/t19-,21-
|
||||
InChIKey |
UBLUCOHGNHINJX-XUTJKUGGSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Lanosterol synthase | Target Info | Inhibitor | [531884] | |
PANTHER Pathway | Cholesterol biosynthesis | ||||
PathWhiz Pathway | Steroid Biosynthesis | ||||
References | |||||
Ref 531884 | Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells. J Med Chem. 2012 Jun 14;55(11):4990-5002. | ||||
Ref 541819 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6715). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.